triazoles has been researched along with Long QT Syndrome in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (28.57) | 29.6817 |
2010's | 12 (57.14) | 24.3611 |
2020's | 3 (14.29) | 2.80 |
Authors | Studies |
---|---|
Liao, X; Yu, Z | 1 |
Anderson, K; Kearney, BP; Kwan, E; Mathias, A; Namour, F; Qin, A; Xin, Y; Yun, C; Zheng, H | 1 |
Han, D; Li, J; Luo, C; Shi, T; Yan, Y; Zhang, Y; Zheng, X | 1 |
Belardinelli, L; Bezzina, CR; Casini, S; Hoekstra, M; Mengarelli, I; Portero, V; Rajamani, S; Remme, CA; Veldkamp, MW; Verkerk, AO; Wilde, AAM | 1 |
Hanretty, AM; Langelier, C; Trang, TP; Yang, K | 1 |
Dunzo, E; Fan, L; Heber, W; Hussaini, A; Iwamoto, M; Khalilieh, SG; Liu, R; Triantafyllou, I; Yee, KL | 1 |
Cutler, DL; Lin, WH; Tendolkar, A; Troyer, MD; Wang, Z; Xuan, F | 1 |
Karamouzos, V; Matzaroglou, C; Panos, G; Tylianakis, M; Velissaris, D | 1 |
Mason, JW | 1 |
Balez, S; Dumortier, T; Sechaud, R | 1 |
Shah, RR | 1 |
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E | 1 |
Kochanek, M; Michels, G; Pfister, R; Shimabukuro-Vornhagen, A | 1 |
Cil, H; Elbey, MA; Islamoglu, Y; Onturk, E | 1 |
Belardinelli, L; Crumb, W; Dhalla, AK; El-Bizri, N; Hirakawa, R; Hu, L; Karpinski, S; Koltun, D; Li, CH; Li, XJ; Liu, G; Rajamani, S; Shryock, JC; Smith-Maxwell, C; Wang, WQ; Wu, L; Yao, L; Zablocki, J | 1 |
Estes, LL; Wilson, JW; Zeuli, JD | 1 |
Hackett, LP; Isbister, GK | 1 |
Nolin, TD; Owens, RC | 1 |
Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R | 1 |
Denning, DW; Williams, KJ | 1 |
Chu, J; Henderson, W; Hoffman, R | 1 |
2 review(s) available for triazoles and Long QT Syndrome
Article | Year |
---|---|
Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.
Topics: Animals; Anticonvulsants; Drug Approval; Drug Design; Drug-Related Side Effects and Adverse Reactions; Humans; KATP Channels; Legislation, Drug; Long QT Syndrome; Triazoles | 2010 |
Antimicrobial-associated QT interval prolongation: pointes of interest.
Topics: Anti-Infective Agents; Antifungal Agents; Biomarkers; Fluoroquinolones; Humans; Imidazoles; Ketolides; Long QT Syndrome; Macrolides; Torsades de Pointes; Triazoles | 2006 |
4 trial(s) available for triazoles and Long QT Syndrome
Article | Year |
---|---|
Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Healthy Volunteers; Heart Rate; Humans; Janus Kinase 1; Long QT Syndrome; Male; Middle Aged; Protein Kinase Inhibitors; Pyridines; Triazoles | 2020 |
A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
Topics: Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Pyridones; Reverse Transcriptase Inhibitors; Triazoles; Young Adult | 2017 |
Preladenant, a selective adenosine A₂A receptor antagonist, is not associated with QT/QTc prolongation.
Topics: Adenosine A2 Receptor Antagonists; Adolescent; Adult; Antiparkinson Agents; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Pyrimidines; Quinolines; Triazoles; Young Adult | 2013 |
Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
Topics: Adolescent; Adult; Aged; Area Under Curve; Aza Compounds; Benzoates; Deferasirox; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Iron Chelating Agents; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Triazoles; Young Adult | 2009 |
15 other study(ies) available for triazoles and Long QT Syndrome
Article | Year |
---|---|
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System(FAERS).
Topics: Antifungal Agents; Bayes Theorem; DNA-Binding Proteins; Humans; Long QT Syndrome; Pharmacovigilance; Retrospective Studies; Software; Torsades de Pointes; Triazoles | 2022 |
Pharmacological corrections of the mutant hERG channels by posaconazole.
Topics: Electrophysiological Phenomena; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Heterozygote; Humans; Long QT Syndrome; Patch-Clamp Techniques; Triazoles | 2021 |
Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cell Line; Epicardial Mapping; Female; Genetic Predisposition to Disease; Heart Rate; Induced Pluripotent Stem Cells; Isolated Heart Preparation; Kinetics; Long QT Syndrome; Male; Mice, Transgenic; Mutation; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Phenotype; Pyridines; Triazoles; Voltage-Gated Sodium Channel Blockers | 2017 |
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2017 |
Long QT Syndrome Leading to Multiple Cardiac Arrests After Posaconazole Administration in an Immune-Compromised Patient with Sepsis: An Unusual Case Report.
Topics: Adult; Antifungal Agents; Female; Heart Arrest; Humans; Immunocompromised Host; Long QT Syndrome; Sepsis; Surgical Wound Infection; Triazoles | 2016 |
Antimicrobials and QT prolongation.
Topics: Anti-Bacterial Agents; Education, Medical; Humans; Ketolides; Long QT Syndrome; Macrolides; Potassium Channels, Inwardly Rectifying; Practice Patterns, Physicians'; Torsades de Pointes; Triazoles | 2017 |
Voriconazole-induced QT interval prolongation and torsades de pointes.
Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole | 2011 |
[53-year-old woman with life-threatening complications after use of ciprofloxacin and posaconazol].
Topics: Anti-Infective Agents; Cardiopulmonary Resuscitation; Ciprofloxacin; Electrocardiography; Female; Humans; Leukemia; Long QT Syndrome; Middle Aged; Risk Factors; Triazoles | 2012 |
OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
Topics: Adult; Antifungal Agents; Cardiac Pacing, Artificial; Cardiopulmonary Resuscitation; Electric Countershock; Electrocardiography; Electrolytes; Female; Humans; Long QT Syndrome; Mitral Valve Insufficiency; Nephrotic Syndrome; Pyrimidines; Rheumatic Heart Disease; Torsades de Pointes; Triazoles; Voriconazole | 2012 |
A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Cnidarian Venoms; Female; Flecainide; Heart Conduction System; Long QT Syndrome; Mutation; Myocardial Ischemia; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Pyridines; Quaternary Ammonium Compounds; Rabbits; Ranolazine; Sodium Channel Blockers; Triazoles | 2013 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antidotes; Biotransformation; Blood Pressure; Charcoal; Depressive Disorder; Drug Overdose; Electrocardiography; Female; Fluid Therapy; Half-Life; Humans; Long QT Syndrome; Piperazines; Triazoles | 2003 |
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Termination of development of D0870.
Topics: Animals; Antifungal Agents; Drug Design; Drug Industry; Humans; Long QT Syndrome; Triazoles | 2001 |
QTc prolongation and drugs.
Topics: Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Histamine H1 Antagonists; Humans; Long QT Syndrome; Loratadine; Oxidoreductases, N-Demethylating; Piperazines; Triazoles | 2001 |